ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MRVI Maravai LifeSciences Holdings Inc

9.93
-0.92 (-8.48%)
29 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Maravai LifeSciences Holdings Inc NASDAQ:MRVI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.92 -8.48% 9.93 9.95 10.69 11.16 10.76 10.96 1,009,349 00:38:44

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023

24/07/2023 9:05pm

GlobeNewswire Inc.


Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Maravai LifeSciences Charts.

Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2023 financial and operating results after the market closes on Monday, August 7, 2023, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

To participate in the conference call by telephone, dial (800) 715-9871 or (646) 307-1963 and reference Maravai LifeSciences, Conference ID 8704315. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.

About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

Contact Information:
Media Contact: Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio 

Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com

1 Year Maravai LifeSciences Chart

1 Year Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

Your Recent History

Delayed Upgrade Clock